The Vanguard Group 13D/13G Filings for Avadel Pharmaceuticals plc (AVDL)

The Vanguard Group 13D and 13G filings for Avadel Pharmaceuticals plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-07-29
3:01 pm
Unchanged
2025-06-30 13G Avadel Pharmaceuticals plc
AVDL
The Vanguard Group 5,564,259
5.740%
0
(Unchanged)
Filing
2025-07-29
3:00 pm
Purchase
2025-06-30 13G Avadel Pharmaceuticals plc
AVDL
The Vanguard Group 5,564,259
5.740%
5,564,259increase
(New Position)
Filing